Chardan Capital Expects Reduced Earnings for Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Chardan Capital decreased their FY2025 EPS estimates for shares of Krystal Biotech in a report issued on Tuesday, April 29th. Chardan Capital analyst Y. Livshits now anticipates that the company will earn $6.15 per share for the year, down from their previous forecast of $7.49. Chardan Capital […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Chardan Capital decreased their FY2025 EPS estimates for shares of Krystal Biotech in a report issued on Tuesday, April 29th. Chardan Capital analyst Y. Livshits now anticipates that the company will earn $6.15 per share for the year, down from their previous forecast of $7.49. Chardan Capital […]
